About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

Academy guidelines for Candida-related endophthalmitis screening now available

The American Academy of Ophthalmology has published its recommendations against routine screening of patients for endophthalmitis caused by Candida septicemia. Source: AAO

Posted on: Feb 4 2022
By: Saratoga Opthalmology
Leave a reponse

Week in review: Retinoblastoma survival rates, generic of Restasis approved, prematurity leads to long-term vision problems

This week, global retinoblastoma survival disparities remain despite progress. the first generic for Restasis is approved in the US, and ophthalmic problems due to prematurity persist into adulthood. Source: AAO

Posted on: Feb 4 2022
By: Saratoga Opthalmology
Leave a reponse

Recurrence of neovascular AMD is common when treatment is suspended

Investigators in Sweden conducted a prospective cohort study to evaluate recurrence of active macular revascularization and visual outcomes in patients who previously underwent anti-VEGF treatment for neovascular AMD. Source: AAO

Posted on: Feb 4 2022
By: Saratoga Opthalmology
Leave a reponse

Nearly 20% of glaucoma surgeries for POAG fail after 5 years

Investigators conducted a retrospective analysis of Medicare claims data to evaluate the economic and reintervention burdens of incisional glaucoma surgery failures. Source: AAO

Posted on: Feb 4 2022
By: Saratoga Opthalmology
Leave a reponse

SARS-CoV-2 viral particles may reach the retina of COVID-19 patients

The authors investigated the presence of presumed SARS-CoV-2 viral particles in the eyes of patients who had died of COVID-19 and found evidence of the virus in multiple layers of the retina and choroid. Source: AAO

Posted on: Feb 3 2022
By: Saratoga Opthalmology
Leave a reponse

COVID-19 vaccination alone is not adequate to prevent SARS-CoV-2 infection

The authors investigated the association of simulated COVID-19 vaccine efficacy and nonpharmaceutical interventions (NPIs) (reduced mobility, school closings, and use of face masks) with rates of infection, hospitalization, and death. Source: AAO

Posted on: Feb 3 2022
By: Saratoga Opthalmology
Leave a reponse

Long-term outcomes of PDS appear comparable to monthly ranibizumab injections

End-of-study results for the extension phase of the phase 2 Ladder trial, comparing use of the Port Delivery System (PDS) and monthly intravitreal injections of ranibizumab for neovascular AMD, suggest comparable efficacy outcomes. Source: AAO

Posted on: Feb 2 2022
By: Saratoga Opthalmology
Leave a reponse

Week in review: Virtual surgical training, appointment follow-up support, bionic eye chip

This week, UK students hone their surgical skills virtually, interactive aids help patients make IOL choices, and a patient with GA receives the first bionic eye chip in the UK. Source: AAO

Posted on: Jan 31 2022
By: Saratoga Opthalmology
Leave a reponse

Oculoplastic surgeons are prescribing fewer longer-acting opioids

In this retrospective cohort study, investigators examined prescribing patterns for extended-release/long-acting (ER/LA) opioids among oculoplastic surgeons listed in the Medicare Part D database. Source: AAO

Posted on: Jan 31 2022
By: Saratoga Opthalmology
Leave a reponse

The MINIject offers promise as a new supracillary MIGS implant

The MINIject glaucoma drainage device, composed of a biocompatible porous silicone material, is a novel implant developed to target the suprachoroidal space. Six-month data have been previously published; this study evaluated the efficacy and safety of the MINIject device over a 2-year follow-up period. Source: AAO